| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 92,263 | 99,815 | 98,078 | 101,823 | | Cost of Revenue | 73,870 | 84,986 | 83,250 | 90,334 | | | Gross Profit | 15,494 | 14,829 | 14,828 | 11,489 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,611 | 4,670 | 6,270 | 6,071 | | Non Recurring | 2,899 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,883 | 10,159 | 8,558 | 5,418 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 145 | (141) | (191) | (87) | | Earnings Before Interest And Taxes | 10,028 | 10,018 | 8,367 | 5,331 | | Interest Expense | 1,495 | 1,402 | 1,468 | 1,498 | | Income Before Tax | 8,533 | 8,616 | 6,899 | 3,833 | | Income Tax Expense | (580) | (226) | (1,615) | (29) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,310 | 10,659 | 9,475 | 4,790 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 120 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,310 | 10,659 | 9,475 | 4,910 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,310 | $10,659 | $9,475 | $4,910 |
|
0.09% Nasdaq 
0.13%
Income Statement
